Furthermore, in CRC patients showing disease progression with the mutated KRAS gene (9/13 patients), significantly higher (p < 0.05) average MAF was noticed (mean ± SD: 11.1 ± 17.4%) compared to the SD group. The gene discussed is KRAS; the disease is colorectal carcinoma.